“…NET is also a target for TCA, NET-selective reuptake inhibitors and psychostimulants, including cocaine, methylphenidate and amphetamine [105,106]. Moreover, NET mutations have been implicated in depression or in some other psychiatric disorders [107,108]. Several polymorphisms have been identified in the human NET gene such as rs5566, rs5563, rs5558, rs5569, rs36024 and rs2242446 variants which were proved to be functional and impact the effect of ADs [109,110].…”